SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-062168
Filing Date
2017-10-13
Accepted
2017-10-13 17:16:58
Documents
6
Period of Report
2017-10-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-23934_38k.htm 8-K 31250
2 EX-1.1 a17-23934_3ex1d1.htm EX-1.1 212569
3 EX-5.1 a17-23934_3ex5d1.htm EX-5.1 13970
4 GRAPHIC g239343kii001.gif GRAPHIC 1808
5 GRAPHIC g239343kii002.gif GRAPHIC 1867
6 GRAPHIC g239343kii003.gif GRAPHIC 4417
  Complete submission text file 0001104659-17-062168.txt   270554
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 171137139
SIC: 2834 Pharmaceutical Preparations